Purple Biotech Ltd
PPBT
$2.53
-$0.1193-4.50%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -19.88M | -21.06M | |
| Total Depreciation and Amortization | -- | -- | 197.00K | 199.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -516.00K | 991.00K | |
| Change in Net Operating Assets | -- | -- | 274.00K | 716.00K | |
| Cash from Operations | -- | -- | -19.93M | -19.16M | |
| Capital Expenditure | -- | -- | -3.00K | -3.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -3.55M | -3.55M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 17.43M | 25.36M | |
| Cash from Investing | -- | -- | 13.88M | 21.81M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -168.00K | -167.00K | |
| Issuance of Common Stock | -- | -- | 1.56M | 1.75M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 4.05M | -286.00K | |
| Cash from Financing | -- | -- | 5.45M | 1.29M | |
| Foreign Exchange rate Adjustments | -- | -- | 54.00K | 89.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -541.00K | 4.03M | |